RT Journal Article
SR Electronic
T1 Estimating the number of undetected COVID-19 cases exported internationally from all of China
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.23.20038331
DO 10.1101/2020.03.23.20038331
A1 Menkir, Tigist F.
A1 Chin, Taylor
A1 Hay, James
A1 Surface, Erik D.
A1 De Salazar, Pablo M.
A1 Buckee, Caroline O.
A1 Watts, Alexander
A1 Khan, Kamran
A1 Mina, Michael
A1 Lipsitch, Marc
A1 Niehus, Rene
YR 2020
UL http://medrxiv.org/content/early/2020/03/30/2020.03.23.20038331.abstract
AB During the early phase of the COVID-19 pandemic, when SARS-CoV-2 was chiefly reported in the city of Wuhan, cases exported to other locations were largely predicted using flight travel data from Wuhan. However, given Wuhan’s connectivity to other cities in mainland China prior to the lockdown, there has likely been a substantial risk of exportation of cases from other Chinese cities. It is likely that many of these exportations remained undetected because early international case definitions for COVID-19 required a recent travel history from Wuhan. Here, we combine estimates of prevalence in 18 Chinese cities with estimates of flight volume, accounting for the effects of travel bans and the timing of Lunar New Year, to approximate the number of cases exported from cities outside of Wuhan from early December 2019 to late February 2020. We predict that for every one case from Wuhan exported internationally, there were approximately 2.9 cases from large Chinese cities exported internationally that likely remained undetected. Additionally, we predict the number of exported cases in six destinations for which predictions on exported cases have yet to be made, surveillance has likely been low, and where health care systems will likely face issues in managing current or potential outbreaks. We observe heterogeneities in exported case counts across these destinations. The predicted number of cases exported to Egypt and South Africa exceeds the predicted number of cases exported to Mauritania. These trends may anticipate differences in the timing and emergence of local transmission in these countries. Our findings highlight the importance of setting accurate travel history requirements for case definition guidelines in the initial phase of an epidemic, and actively updating these guidelines as the epidemic advances.Competing Interest StatementThe authors have declared no competing interest.Funding StatementML, TFM, TC and RN were supported by Award Number U54GM088558 from the US National Institute Of General Medical Sciences. PMD was supported by the Fellowship Foundation Ramon Areces. COB was supported by a NIGMS Maximizing Investigator’s Research Award (MIRA) R35GM124715-02.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesTransformed flight data, derived prevalence data, and all code used in these analyses are fully available online at https://github.com/c2-d2/COVID_allchina_export https://github.com/c2-d2/COVID_allchina_export